Psychedelics No Better Than Antidepressants

A recent analysis of research indicates that psychedelic drugs, such as those found in magic mushrooms and LSD, do not offer superior results compared to standard antidepressants for individuals suffering from major depression. The comprehensive review, published in JAMA Psychiatry, pooled data from multiple clinical trials.

Researchers compared the outcomes of psychedelic-assisted therapy against open-label trials of antidepressants. This method aimed to neutralize the placebo effect by ensuring participants in both groups were aware they were receiving a treatment. The findings revealed comparable improvements in depression scores, with both approaches reducing symptoms by approximately 12 points on a 52-point scale.

This outcome challenges the widely held enthusiasm for psychedelics as a breakthrough mental health treatment. The study suggests that prior trials showing significant benefits for psychedelics may have been influenced by participants' expectations rather than the drugs' inherent efficacy. While not discounting their potential, the research emphasizes the need for rigorous, direct comparisons to understand the true therapeutic advantages of psychedelics over established treatments.